Tami Martin, R.N.

2018

In 2018, Tami Martin, R.N. earned a total compensation of $725K as Senior Vice President, Regulatory Affairs at Supernus Pharmaceuticals, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$98,622
Option Awards$278,326
Salary$307,661
Other$40,430
Total$725,039

RN received $307.7K in salary, accounting for 42% of the total pay in 2018.

RN also received $98.6K in non-equity incentive plan, $278.3K in option awards and $40.4K in other compensation.

Rankings

In 2018, Tami Martin, R.N.'s compensation ranked 10,564th out of 14,244 executives tracked by ExecPay. In other words, RN earned more than 25.8% of executives.

ClassificationRankingPercentile
All
10,564
out of 14,244
26th
Division
Manufacturing
4,252
out of 5,762
26th
Major group
Chemicals And Allied Products
1,602
out of 2,125
25th
Industry group
Drugs
1,353
out of 1,814
25th
Industry
Pharmaceutical Preparations
1,042
out of 1,388
25th

Pay ratio

Tami Martin, R.N.'s Pay$725,039
Median Employee's Pay$131,026
Pay Ratio

to 1

In 2018, the annual total compensation of Tami Martin, R.N. was $725,039.

The annual total compensation of the median employee at Supernus Pharmaceuticals was $131,026.

The ratio of Tami Martin, R.N.'s pay to the pay of median employee was therefore to one.

Source: SEC filing on April 24, 2020.

RN's colleagues

We found five more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2018.

2018

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2018

Stefan Schwabe

Supernus Pharmaceuticals

Chief Medical Officer

2018

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2018

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

2018

Victor Vaughn

Supernus Pharmaceuticals

Former Senior Vice President of Sales and Marketing

News

You may also like